A compound with anti-inflammatory and cartilage-protecting properties. It shields your joints, thins blood slightly, and calms inflammation. Clinically used for bladder conditions (interstitial cystitis) and joint health.
Dosing
2-3 mg per kg of body weight subq twice a week, or 100 mg by mouth 3 times daily. Cycle for 8-12 weeks.
Benefit Profile
Published Research
Risk and Dose-Response Relationship for Pentosan Polysulfate Sodium Maculopathy: A Systematic Review and Meta-Analysis.
Efficacy of pentosan polysulfate for the treatment of interstitial cystitis/bladder pain syndrome: results of a systematic review of randomized controlled trials.
Efficacy of pentosan polysulfate in the treatment of interstitial cystitis: a meta-analysis.
Pentosan polysulfate regulates hepcidin expression in native Mongolian horses.
Pentosan polysulfate maculopathy: clinical considerations, pathobiology, and causality.
Pentosan polysulfate sodium maculopathy: Final analysis of a prospective cohort, updated review, and association with inflammatory bowel disease.
A review of the clinical efficacy and adverse effects of disease modifying osteoarthritic drugs (DMOADs) in dogs with special focus on glucosamine and pentosan polysulfate; do they work?
Pentosan polysulfate and a pigmentary maculopathy: causation versus correlation?
Pentosan polysulfate maculopathy.
Pentosan Polysulfate, a Semisynthetic Heparinoid Disease-Modifying Osteoarthritic Drug with Roles in Intervertebral Disc Repair Biology Emulating the Stem Cell Instructive and Tissue Reparative Properties of Heparan Sulfate.